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Disordered domains are long regions of intrinsic disorder that ideally have 
conserved sequences, conserved disorder and conserved functions. These domains 
were first noticed in protein–protein interactions that are distinct from the interactions 
between two structured domains and the interactions between structured domains 
and linear motifs or molecular recognition features (MoRFs). So far, disordered 
domains have not been systematically characterized. Here, we present a 
bioinformatics investigation of the sequence–disorder–function relationships for a set 
of probable disordered domains (PDDs) identified from the Pfam database. All the 
Pfam seed proteins from those domains with at least one PDD sequence were 
collected. Most often, if a set contains one PDD sequence, then all members of the 
set are PDDs or nearly so. However, many seed sets have sequence collections that 
exhibit diverse proportions of predicted disorder and structure, thus giving the 
completely unexpected result that conserved sequences can vary substantially in 
predicted disorder and structure. In addition to the induction of structure by binding to 
protein partners, disordered domains are also induced to form structure by disulfide 
bond formation, by ion binding, and by complex formation with RNA or DNA. The two 
new findings, (1) that conserved sequences can vary substantially in their predicted 
disorder content and (2) that homologs from a single domain can evolve from 
structure to disorder (or vice versa), enrich our understanding of the sequence  
disorder ensemble  function paradigm. 
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Statement: Highly conserved sequences in a protein family vary significantly in their 
amount of predicted disorder and structure. The diversity of disorder and structure 
within a protein family implies associated changes in functional behavior and in 
evolutionary selection. Intrinsic sequence propensity is subject to various 
stabilization factors – such as disulfide bonds, ion binding, and macromolecule 
binding – that can induce disordered domains to form a stable structure. 
 
Abbreviations: IDPs or IDRs, intrinsically disordered proteins or regions; PDD, 
probable disordered domain; PDB, Protein Data Bank; NMA–NIA, normalized 
monomeric area and normalized interface area; VSL2b, disorder predictor trained on 
V = variously characterized proteins with S = short and/or L = long IDRs, version 2b; 
CDF, cumulative distribution function; CH, charge–hydropathy; NMR: nuclear 
magnetic resonance; kip, kinase inhibitor protein; SCOP, Structural Classification of 
Proteins; CATH, class, architecture, topology, and homology.  
  




Molecular biologists and geneticists use domain for a contiguous set of amino 
acids having a particular function, e.g. the autoinhibitory domain1,2 and the 
transactivation domain.3,4 Such domains are often located within intrinsically 
disordered protein regions and undergo disorder-to-structure transitions upon 
binding to their partners.4,5 In contrast, structural biologists initially used domain to 
describe a protein unit that folds autonomously6 and has functional autonomy, and/or 
evolutionary conservation.7,8 
Domain databases based on evolutionary conservation include Pfam,9,10 
SMART,11 and the Conserved Domain Database (CDD).12 Domain databases based 
on structural autonomy include the Structural Classification of Proteins (SCOP)13 and 
Class, Architecture, Topology, and Homology (CATH).14 Finally, a database based 
on both evolutionary conservation and structural autonomy is SUPERFAMILY.15 
In contrast to structured proteins, intrinsically disorder proteins and regions 
(IDPs and IDRs) lack stable structures in solution; existing instead as highly dynamic 
ensembles with thousands of conformations.16-20 Many IDPs and IDRs undergo 
disorder-to-structure transitions upon binding partners.21,16-20 These disorder-to-
structure changes upon binding are often incomplete with flanking or looping IDRs22 
that sometimes contribute positively or negatively to the binding constant. Such 
complexes are called fuzzy.23,24 Some fuzzy complexes remain entirely disordered 
and bind with high affinity.25 Structure-to-disorder transitions upon binding have also 
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been observed for some proteins,26-28 with at least one protein showing simultaneous 
structural changes in both directions for different regions.26  
IDPs and IDRs are abundant in all domains of life.29-31 IDPs, IDRs, and their 
various interactions with partners of all types32 are critically involved in many 
biological processes, such as molecular recognition, signaling, regulation, and cell 
cycle control33-35,20,36,37 among many others.38,39 
In one study, the large majority of IDRs exhibited significantly less sequence 
conservation than the structured regions of the same proteins.40 Follow-up studies 
have shown that conserved-sequence IDRs are also common.41,42 Conserved-
sequence IDRs were more recently called constrained disorder42 and are correlated 
with tissue-specific alternative splicing and cell regulation.43 One IDR is conserved in 
length and dynamic behavior but has negligible sequence conservation;44 such 
segments are called conserved (or flexible42) disorder. Some IDR sequences are not 
conserved and change from being predicted-to-be disordered to being predicted-to-
be structured; these regions are called non-conserved.42 Finally, insertions and 
deletions (IDELs) are more often disordered than structured45-47, and some IDR 
deletions are observed to occur in paralogues.48  In summary, from an evolutionary 
point of view, there are four types of IDRs: (i) conserved-sequence (or constrained) 
disorder; (ii) variable-sequence (or flexible) disorder; (iii) non-conserved disorder, 
and (iv) INDELs. 
IDPs and IDRs carry out molecular recognition49 and disorder predictors have 
been used to identify specific IDP and IDR loci that bind to globular protein 
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partners.50 IDR-located binding sites have been identified by disorder 
prediction,34,51,52 and, alternatively, by linear sequence motifs.53-55 Globular protein 
partner binding by IDPs and IDRs is common across the three domains of life.56 
These prediction-based studies have focused on short segments (5–15 residues in 
length) located within longer IDRs or even within IDPs. 
Much longer IDRs (≥20–30 residues in length) bound to globular protein partners 
and the previous work on conserved-sequence disorder41 show that such regions 
have conserved functions, conserved sequences, and conserved disorder, and so, 
by analogy to structured domains, such IDPs or IDRs were called disordered 
domains57. An especially interesting disordered domain example is found in p27kip1, 
p21Waf1/Cip1/Sdi and p57kip2.58-60 All three of these proteins have domains that are 
entirely disordered by both prediction and experiment and play similar key regulatory 
roles in controlling the cell cycle. 
Like p27kip1 and its homologues, many Pfam domains contain sequences with 
100% predicted intrinsic disorder.57,61,62 It is noteworthy that the Pfam database 
recently added “disordered” as a specific entry type,10 suggesting that the definition 
of protein domains should now also include those that are intrinsically disordered.  
In the current work, we analyzed the sequences, the induced structures, and the 
functions for a set of Pfam disordered domains to explore their sequence–disorder–
function relationships. The results presented herein highlight interesting distinctions 
between disordered and structured domains and improve our understanding of 
protein sequence–disorder–function relationships. 




Analysis of probable disordered domains (PDD) 
The workflow for analysis of PDD is shown in Figure1. As indicated in Materials 
and Methods, 206 PDDs were obtained based on the set of PDD seed sequences 
from a previous study.61 First, as indicated in Figure1 on the left, the homologues to 
the PDD sequences were collected, giving a total of 19,577 sequences. These 
homologues were collected from the seed proteins for each Pfam domain having at 
least one PDD sequence. These homologues in the seed alignment were used to 
correlate sequence conservation with predicted disorder, and to investigate the 
sequence–disorder relationships. Not used here are the many additional 
homologous sequences matching the full alignment that could have been found by 
application of the hidden Markov model predictors developed for each Pfam domain; 
if such domains were included, the number of PDDs could be greatly increased. Next, 
as indicated in Figure1 on the right, 2,548 different structures from 110 domains 
were collected for members having available structures in PDB. Their likely 
mechanisms of disorder-to-structure transition were examined to further investigate 
disorder–function relationships. 
Sequence–Disorder relationships: unexpected wide range of predicted 
disorder/structure among homologous sequences 
Disorder prediction was applied to all the collected seed members for the PDDs. 
It was expected that the additional homologous sequences of the PDD seeds would 
also show highly predicted disorder. Such a result was indeed commonly observed 
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[Fig. 2(A)], with 78 (38%) of the Pfam domains having predicted disorder (defined by 
an average vsl2b score >0.6 for all of the associated seed proteins, and with an 
additional 69 (33%) of the Pfam, having predicted disorder PDD for more than half of 
the seed proteins and with substantial predicted disorder in most of the remaining 
seed proteins (see Materials and Methods and Fig. S1 for more details). Thus, a total 
of 147 (71%) Pfam domains were found to be all or mostly predicted-to-be-
disordered as expected. Totally unexpected was that finding that four Pfam domains 
(2%) were found to contain equal numbers of predicted to be disordered and 
predicted to be structured members and that 55 Pfam domains (27%) were found to 
contain mostly predicted-to-be-structured members with only a few predicted 
disorder members [Fig. 2(A)]. 
Thus, four groups having distinct seed member compositions were observed as 
shown in the pie chart of Figure 2(A). In each group, one domain example is 
presented by mapping the average VSL2b score into Pfam phylogenetic trees, 
where red and blue indicate predicted-to-be-disordered and predicted-to-be-
structured seeds, respectively. In the latter three groups, there were 56 domains that 
contained both fully predicted-to-be-disordered (100% residues with VSL2b 
score >0.5) and fully predicted-to-be-structured seeds [100% residues with VSL2b 
scores <0.5, Fig. 2(B)].  
Overall, the disorder prediction showed significant diversity, as shown in Figure 
2(C) for all the seeds (predicted disorder percentage ranged from 0% to 100%) and 
in Figure 2(D) across the domains (average predicted disorder percentage ranged 
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from 13% to 100%), respectively. Among the 19,577 seeds, only 30% of them (5,833) 
were PDD [highlighted in the red bar in Fig. 2(C)], and 14% (2,755) of them were 
predicted to be fully structured [0% residues predicted to be disordered, highlighted 
in the blue bar in Fig. 2(C)]. Also, only 74 of the 206 domains (36%) were predicted 
to be >95% disordered [highlighted in red bar in Fig. 2(D)]. The wide range of 
predicted disorder or structure for the homolog sequences within a domain is 
completely unexpected. This observation was validated on a larger set of 
representative proteomes reduced to a sequence identity of 55%. The disorder 
contents in both sets showed close agreement across all domains studied (Fig. S2), 
which suggests the seed sequence set does not contain a biased order-disorder 
content. These striking differences of predicted disorder or structure suggested that, 
for these domains, their sequences are likely more conserved than their structures. 
Thus, the widely held view that structure is more strongly conserved than 
sequence63-67 is clearly not followed by all IDP or IDR domains, which instead often 
show the unexpected contrary behavior that sequence is more strongly conserved 
than structure. 
Further investigation of sequence conservation indeed shows that conserved 
positions have higher disorder prediction scores on average than non-conserved 
positions in PDDs [Fig. S3(A)]. The structured domain set showed similar pattern 
[Fig. S3(B)]. Therefore, many PDDs contain conserved sequences, and conserved 
disorder, which is similar to structured domains having conserved sequences and 
conserved structure. 
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The evolutionary origins of these structural differences was investigated by 
calculating the disorder content of the last common ancestor of each domain (Fig. 3).  
In many cases, the estimated disorder content of the domain ancestor is consistent 
with overall disorder content of domain examples, which indicates that different 
structural differences may be an ancient feature of these domains.  However, in a 
few cases, disorder is significantly different in the domain ancestor than in the 
domain examples, either higher in three cases (Fig. 3: PF00560, PF01821, 
PF00096), or lower in one case (Fig. 3: PF00641).  This seems to indicate a 
structural shift from disorder to order, or order to disorder, in these domain across 
evolutionary history. 
Unusual disorder-function relationships: disorder-to-structure transition upon 
various mechanisms 
Given the wide range of disorder and structure within a domain, we first 
examined the distribution of disorder prediction for the identified PDB structures. This 
was done to exclude the possibility that domains could form structures simply 
because they are predicted-to-be structured members. Histograms in Figure 4(A) 
confirmed that majority of identified structures were predicted to be disordered on 
their sequences, with only a small set (109, 11.7%) predicted to be fully structured. 
An obvious question is why do predicted-to-be-disordered proteins have structures in 
PDB? 
Regarding the existence of structures for the predicted-to-be-disordered proteins, 
three mechanisms were found that could potentially bring about disorder-to-structure 
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transitions: (i) disulfide bond formation; (ii) ion binding; and (iii) macromolecular 
binding. In addition, there is a fourth group for which the stabilization mechanisms 
are uncertain or inconsistent. For each group, the numbers of domains and 
structures, and the range of the average predicted disorder are summarized in Table 
1. Percentage of disordered residues for each structure was averaged over all 
structures for each domain type. The distribution of average percentage of predicted 
disorder in the four different groups is shown in Figure 4(B). The first three groups 
had significantly higher predicted disorder than the fourth, and many of domains in 
the first three groups have experimental evidence supporting disorder-to-structure 
transitions that depend on the indicated stabilizing factors. Particularly, the intrinsic 
disorder for the macromolecular-binding domains was verified by searching for 
experimental evidence in literature. The stabilization factors for the fourth group are 
discussed in more detail in the Supplemental Material (Table S2 and the text below 
the table). Here, we discuss the first three groups. 
Disorder-to-structure transitions upon disulfide bond formation or ion binding 
Disulfide bonds are formed by oxidation of thiol groups between cysteines in a 
relatively oxidizing environment. Because the interior of cells is a reducing 
environment, disulfide bonds are usually not found in intracellular proteins but 
instead are found in extracellular, secreted and periplasmic proteins,68 although they 
can also be formed in cytoplasmic proteins under certain conditions,69 such as 
oxidative stress.70 Among the 25 disfulfide-bond-containing domains, most of them 
(22 domains) are secreted proteins (annotation from UniProt), two (PF06747, 
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PF05051) are found in the intermembrane space of mitochondria and the remaining 
one (PF09256) is an extracellular domain found in membrane receptors, so the 
environment of this example is similar to that of a secreted protein. Some secreted 
proteins in gram negative bacteria have been shown to be unfolded inside the cell 
because structure-inducing disulfide bonds remain unconnected in the reducing 
conditions, and then adopt structures outside the periplasm as a result of disulfide 
bond formation in the oxidative environment.71 In eukaryotes, disulfide bond 
formation in secreted proteins involves the endoplasmic reticulum and is more 
complicated, but still depends on movement from a reducing environment to a more 
oxidative environment.72 Furthermore, recent work in bacteria shows that their 
secreted proteins need to be at least partially unfolded inside the cell in order to 
interact with the secretion apparatus and become folded outside the cell, where the 
extra-cellular folding is brought about not just by disulfide bond formation but by a 
variety of mechanisms.73  Thus, secreted proteins represent a new cohort that are 
transiently disordered and have been called “delayed folding proteins”.74  The 
observation that the delayed folding of many secreted proteins is regulated by 
disulfide bond formation confirms our previous conjecture62 that disordered domains 
that become folded by disulfide bond formation are likely secreted proteins that 
remain unstructured inside the cell and then gain structure outside the cell following 
secretion.69,72-74 
Proteins with ion binding functions are significantly enriched in IDPs.75  Various 
types of ions, such as Ca2+, Zn2+, Cd2+, Co2+, Mg2+, Cu2+ and Na+, have been 
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identified in the current study. Among these, Zn2+ binding is the most commonly 
found type. This is consistent with our previous findings that zinc fingers are the 
second among the top 20 domains that are strongly correlated with predicted 
disorder,35 and zinc is the third among the top 20 ligand keywords that are strongly 
correlated with predicted disorder.38 The folding of a typical zinc finger depends on 
the binding of Zn2+ – the conformation changes from an unfolded state into a highly 
folded structure in the presence of zinc.35,76 In addition, Gla domains (PF00594) are 
mostly disordered in the absence of calcium ions and undergo a disorder-to-structure 
transition upon calcium binding, suggesting that calcium ions are required for proper 
Gla-domain folding.77 
Disorder-to-structure transition upon DNA- / RNA/ protein binding   
A set of domains that function via induced folding upon DNA or RNA binding was 
collected. Evidence of disorder-to-structure transition upon DNA/RNA binding is 
known for all the examples in this study (summarized in Table S3). For instance, 
DNA-induced folding of the basic regions of HLH domains (Fig. 5) is well 
documented. HLH domains are developmental regulators of transcription and 
generally function as dimers, with each monomer containing a basic region (~18 
residues) necessary for DNA binding, a helix–loop–helix motif (~34 residues), and a 
leucine-zipper region (~30 residues) (Fig. 5). The basic region was predicted to be 
disordered [Fig. 5(A)], which is supported by NMR data demonstrating that this 
region of the Max protein is poorly folded in the absence of DNA78 [Fig. 5(B)], but 
acquires an α-helical conformation upon binding to DNA [Fig. 5(C)]. This activity has 
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also been reported in MyoD79 and USF proteins,80 supporting our predictions of HLH 
disorder [Fig. 5(A)] and suggesting that the disordered basic region is required for 
DNA recognition. 
Predicted disorder or structure was examined in more detail by sequence 
alignment and structural superposition for Methly-CpG binding domain (MBD, 
PF01429). MBD includes members predicted to be structured and fully disordered 
(from 1% to 100% disorder). The multiple sequence alignment suggests 15 highly 
conserved residues, several of which are directly involved in methyl-CgG binding 
based on available PDB structures (Fig. 6). Obvious conformational changes were 
observed when comparing the least and most disordered members [Fig. 6(A), 6(D)]. 
Protein-binding PDDs contained two groups: disordered protein binding and 
structured protein binding. All of the PDDs found here were predicted to be 
disordered by structure-based normalized monomeric area and normalized interface 
area (NMA–NIA) analysis (see supplemental methods for more detail), and most of 
them were also predicted to be highly disordered (>75% of the residues) by the 
sequence-based VSL2b predictor, suggesting a strong consistency between these 
two methods [Fig. S4(A)]. Most PDDs were bound to structured partners. Selected 
examples were labeled by their PDB ids and their structures in the binding 
complexes were shown in Figures S4(B–G). All the disordered domain structures 
lack globularity, and experimental evidence of intrinsic disorder in the absence of 
their binding interactions were found for 56 examples (summarized in Table S3).  
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Overall, the apparent contradiction between the prediction of disorder and 
existence of PDB structures can be reconciled for the majority of the examples 
because of the various stabilization factors described above that bring about 
disorder-to-structure transitions. These transitions make disordered domains distinct 
from well-structured domains with regard to the mechanisms underlying of protein–
protein and protein-nucleic acid interactions. 
  




A surprisingly wide range of predicted disorder was observed among the 
homologues within many individual domains 
Prediction of disorder or structure is strikingly different for homologous 
sequences within many of the different Pfam domains. Sets of seed proteins varied 
from 13% (PF00023, Ank) to 100% disorder on average among the domains. Of 
these, only ~36% (75 of 206 domains) were predicted to be >95% disordered on 
average. When examining the disorder prediction of individual members for a given 
domain, the percentage range was even wider, ranging from fully ordered to fully 
disordered. We did not expect that proteins suggested to be homologues by hidden 
Markov models in Pfam would show such a wide range of predicted disorder. These 
results are certainly contrary to the general view that structure is more highly 
conserved than sequence.63-67  
Disordered domains form structures as a result of various mechanisms 
Various mechanisms cause disordered domains to form structures, including 
disulfide bonds, ion coordination, macromolecular partner binding, and many others. 
These major three factors are known to assist protein folding, and was used to divide 
disordered domains in previous work.62 The examination of structural characteristics 
provides reasonable explanations of prediction of disorder and formation of structure 
for PDDs. This investigation suggests that future disorder predictors should consider 
these specific types of intrinsic disorder, which are likely to be distinct from IDPs or 
IDRs that don’t undergo disorder-to-structure transitions. 
This article is protected by copyright. All rights reserved.
 
  
Different disorder amount is likely related to crucial functional differences 
Given the significantly different amount of predicted disorder among members in 
the same domain, it raises the question whether this correlates with their distinct 
functions. Experiment studies that correlate the disorder amount with functional 
differences remain largely un-investigated, although distinct functions between 
different domain members are known for many examples. For instance, the Gγ 
domain (PF00631) has two members (Gγ1 and Gγ2) with significantly different 
amounts of predicted disorder (100% and 33%, respectively). Evidence shows that 
both Gγ1 and Gγ2 bind to the same partner (Gβ1), forming β1γ1 and β1γ2 dimers 
having significant differences in their functions.81,82 An experimental investigation of 
whether there is truly a correlation between functional differences and intrinsic 
disorder in Gγ would be of great interest. 
This work raises important questions about homologous domains that contain 
both predicted-to-be-disordered and predicted-to-be-structured members. For 
example, what are the underlying selective advantages that influence a predicted-to-
be-disordered domain to evolve into a predicted-to-be-structured domain or vice 
versa?  These conserved-sequence-associated changes in structure from disorder-
to-structure or vice versa might be associated factors such as gain-or-loss-of-
function arising from the altered structural tendency, or such as increased resistance 
or increased sensitivity to regulatory protease digestion. Also, what are the detailed 
changes in sequence that enable a sequence to change from predicted-to-be-
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structured into predicted-to-be-disordered (or vice versa) while still being indicated to 
be conserved by hidden Markov models? Work on these questions is in progress. 
In summary, here we provide further evidence for the existence of intrinsically 
disordered domains. We show that many disordered Pfam domains have conserved 
sequences, conserved disorder, and conserved functions, which is analogous to the 
definition of structured domains, which have conserved sequences, conserved 
structures, and conserved functions. Our findings strongly support disordered 
domains as a new type of protein functional element that is distinct from classic 
structured domains. Our findings also suggest that disordered domains have the 
unexpected capacity to evolve from disorder to structure (or vice versa) over time.  
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MATERIALS AND METHODS 
Datasets 
Structured Protein Dataset 
664 structured proteins were derived from non-redundant (sequence identity 
<25%) X-ray crystallography structures from PDB. These are single chain monomers 
having no missing density, no disulfide bonds/ions/small molecules, and not 
including secreted proteins and coiled coils (because these proteins often predicted 
to be disordered). 
IDP and IDR Dataset 
113 IDPs and 692 IDRs were obtained from DisProt.39 Only regions longer than 
20 consecutive residues were included for further analysis. 
Probable disordered domain (PDD) dataset 
The initial disordered dataset contained a set of domain seed members for which 
all of their residues were predicted by VSL2b to have scores >0.50.61 The term 
“domain” here refers to a Pfam-A entry. Each Pfam entry includes a set of 
representative members of the family, hidden Markov models built from the seed 
alignment, and the automatically generated full alignment containing the proteins 
belonging to the entry. The term “seed” here refers to an individual protein sequence 
(in part or in whole) from the seed alignment. The term “member” here refers to an 
individual protein from the seed alignment, or full alignment, and the difference is 
spelled out.  
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The previously used requirement that all residues have VSL2b scores >0.5061 is 
too restrictive and misses many experimentally confirmed IDPs. Two methods have 
been used to estimate whole protein disorder, the charge-hydropathy plot83,84 and 
the cumulative distribution function.34,85 However, neither of these methods has been 
extended for the problem of distinguishing structured protein regions from IDRs, and 
many disordered Pfam domains are IDRs rather than IDPs. Thus, we developed a 
new approach using the average value of per-residue VSL2b predictions of disorder 
that we tested for both IDPs and IDRs. In plots of the histograms of the VSL2b 
average values for the 664 structured proteins, the 113 IDPs and the 692 IDRs in the 
dataset described above, values in the range of 0.4 to 0.6 gave good separations of 
the structured proteins from both the IDPs and IDRs as shown in Figure S1. Not one 
of the structured protein exhibited an average VSL2b score >0.60, so we used this 
value here.  
For the set of PDD sequences using VSL2b scores >0.60, 206 domain entries 
were identified, and considered as PDDs. Each chosen domain had at least one 
seed that was identified as a PDD by this criterion. 
Disorder prediction 
Disorder prediction was used to examine whether or not additional homologs of 
the PDD sequences were also highly predicted to be disordered. All the seed 
sequences of the 206 domains were collected and predicted for disorder on the 
whole parent Uniprot sequences using the PONDR VSL2b predictor. Seed 
sequences were chosen because these are manually selected by Pfam for 
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significant sequence identity with each other and more likely to contain additional 
disordered homolog within a domain having PDD seeds. VSL2b was used because it 
showed the best overall performance for long IDRs (≥30 consecutive residues) in a 
comprehensive comparison of 19 predictors.86 Since the length of disordered 
domains was proposed to be over 20–30 residues,57 it is expected that VSL2b would 
show good accuracy. We also chose this predictor for the reason of consistency (it 
was used in our previous work61 for the statistical analysis). 
Classify PDDs by distinct seed compositions 
To examine the seed member composition for each PDD, average disorder 
scores by VSL2b on seed sequences were used to partition the domains into groups. 
The sequences with average disorder score >0.6 were defined as predicted-to-be-
disordered seed members, and those with average disorder score <=0.6 were 
defined as predicted to be ordered seed members. In each domain, the numbers of 
the two types of seeds were calculated, and four groups were classified: (1) domains 
containing all predicted-to-be-disordered seeds; (2) domains containing mostly 
predicted-to-be-disordered seeds; (3) domains containing equal numbers of seed 
types (number difference less than 2); (4) domains containing mostly predicted-to-
be-structured seeds.  
Evolutionary relationships between ordered and disordered seeds were 
examined with domain sequence-based phylogenies. Phylogenies were built from 
Pfam model domain alignments using FastTree87 and rooted by the midpoint 
method.88 The maximum likelihood disorder content and 95% confidence intervals of 
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the last common ancestor of each domain family, according to phylogeny midpoint, 
was determined.89 Plots of domain families were branch length-scaled by node depth 
for display, but ancestors were colored according to their estimated disorder content 
using the original branch lengths. Phylogenetic analysis and plotting was performed 
with the R package phytools.90  
Examination of structure/disorder–function relationship 
To examine the structure/disorder–function relationship for the PDDs, X-ray and 
NMR structures in PDB were identified and possible mechanisms of disorder-to-
structure transition were provided. Matched PDB structures for the domains were 
from members in Pfam full alignment. As the focus was on the PDDs, structures with 
multiple domains on the target chains were removed for further analysis. Short 
matched peptides (<20 residues) were also not included. Sequence-based 
disordered predictions were applied to the whole parent UniProt sequences of the 
structural members and the average percentage of predicted disorder was calculated 
for each matched domain region.  
Next, likely mechanisms of structural formation for these predicted-to-be-
disordered domains were used to partition them into four groups. These are: (a) 
domains form structures because of disulfide bonds; (b) domains that form structures 
because of ion binding; (c) domains that form structures because of macromolecular 
binding; and (d) domains form structures with no consistent mechanism for structure 
formation. The method for partitioning into these groups is the same as that used in 
our previous work.62 
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Figure S1 Using average VSL2b score to determine the threshold for IDPs, IDRs and 
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Table 1 likely mechanism for predicted-to-be-disordered domains to form PDB structures 
Groups of stabilization factors Numbers of 
domains 
Numbers of  
PDB chains 
Range of average predicted 
disorder% (median) 
Disulfide bonds 25 267 26–100% (72%) 
Ion-binding 16 419 19–100% (74%) 
Macromolecular-binding 60 1084 12–100% (100%) 
Uncertain stabilization mechanisms 7 16 52–100% (100%) 11 357 17–74% (34%) 
 
  




Figure 1. Workflow for analysis of probable disordered domains in Pfam database. 
Figure 2. Significant diversity of predicted disorder among the homolog sequences 
within PDDs. (A) The pie chart showing the numbers and percentage of domains 
having different compositions of seed members. In each group, examples were 
presented as the Pfam phylogenetic trees mapped with average VSL2b disordered 
score into each sequence. (B) A set of 56 PDDs having both 100% predicted-to-be-
disordered and 100% predicted-to-be-structured members. The distribution of 
predicted disorder percentage for each domain is shown as boxplots. (C) Distribution 
of predicted disorder percentage of all the 19577 seeds. (D) Distribution of average 
predicted disorder percentage for 206 domains.   
Figure 3.  Estimated disorder content of the last common ancestor of each of the 56 
PDDs having both 100% predicted-to-be-disordered and 100% predicted-to-be-
structured members.  The estimated percentage disordered residues of the ancestor 
(circles) and the 95% confidence interval of the estimate (error bars) are plotted 
along with the median percentage disordered residues (X) for comparison.  
Figure 4. Identified structures were mostly predicted to be disordered on their 
sequences. (A) Prediction of disorder on matched structures. (B) Distribution of 
average predicted disorder for the four groups. MBD: macromolecular-binding 
domains. Ion: ion-binding. SS: disulfide bonds. Non-consistent: domains without 
consistent mechanism of structural formation. 
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Figure 5. DNA-induced folding of the disordered basic region from HLH domain of 
human Max protein. (A) VSL2b disorder prediction for the sequences. Red: disorder; 
blue: order; white: ambiguous. (B) NMR structure of the HLH domain in the absence 
of DNA (PDB id: 1R05). Basic region: 1–18 residues. Helix–Loop–Helix: 19–53 
residues. Leucine zipper: 54–87 residues. (C) X-ray structure of the HLH domain 
bound with DNA (PDB id: 1NKP). The two structures represent the same regions 
(23–102 residues) from human Max protein (UniProt ID: P61244). DNA chains are 
colored in light blue and green. 
Figure 6. Diversity of structure/disorder in the MBD domain (PF01429). Top: multiple 
sequence alignment was carried out by T-coffee and displayed by ESPript 3.0. 
Predicted disorder for the sequences increases from top (structure) to bottom (full 
disorder). The asterisk (*) at the bottom of the alignment indicates highly conserved 
DNA binding sites Four available structures were shown below. (A) A structural 
member (PDB id: 3VXV, chain A). (B) A mediate disordered member (PDB id: 2MOE, 
chain A). (C) A higher disordered member (PDB id: 1QK9, chain A).  (D) A fully 
disordered member in its DNA bound state (PDB id: 6CCG, chain A). (E) 
Superposition of the least and fully disordered member (sequence identity 42%) in 
their bound state. The binding partners are not shown here. 
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Figure 3.  Estimated disorder content of the last common ancestor of each of the 56 PDDs having both 
100% predicted-to-be-disordered and 100% predicted-to-be-structured members.  The estimated 
percentage disordered residues of the ancestor (circles) and the 95% confidence interval of the estimate 
(error bars) are plotted along with the median percentage disordered residues (X) for comparison. 











Figure 4. Identified structures were mostly predicted to be disordered on their sequences. (A) Prediction of 
disorder on matched structures. (B) Distribution of average predicted disorder for the four groups. MBD: 
macromolecular-binding domains. Ion: ion-binding. SS: disulfide bonds. Non-consistent: domains without 
consistent mechanism of structural formation. 











Figure 5. DNA-induced folding of the disordered basic region from HLH domain of human Max protein. (A) 
VSL2b disorder prediction for the sequences. Red: disorder; blue: order; white: ambiguous. (B) NMR 
structure of the HLH domain in the absence of DNA (PDB id: 1R05). Basic region: 1–18 residues. Helix–
Loop–Helix: 19–53 residues. Leucine zipper: 54–87 residues. (C) X-ray structure of the HLH domain bound 
with DNA (PDB id: 1NKP). The two structures represent the same regions (23–102 residues) from human 
Max protein (UniProt ID: P61244). DNA chains are colored in light blue and green. 











Figure 6. Diversity of structure/disorder in the MBD domain (PF01429). Top: multiple sequence alignment 
was carried out by T-coffee and displayed by ESPript 3.0. Predicted disorder for the sequences increases 
from top (structure) to bottom (full disorder). The asterisk (*) at the bottom of the alignment indicates 
highly conserved DNA binding sites Four available structures were shown below. (A) A structural member 
(PDB id: 3VXV, chain A). (B) A mediate disordered member (PDB id: 2MOE, chain A). (C) A higher 
disordered member (PDB id: 1QK9, chain A)  (D) A fully disordered member in its DNA bound state (PDB id: 
6CCG, chain A). (E) Superposition of the least and fully disordered member (sequence identity 42%) in their 
bound state. The binding partners are not shown here. 
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